Altair Therapeutics' Series A - II Round

Altair Therapeutics raised a round of funding on November 06, 2009.

Altair Therapeutics is a biotechnology company focused on the discovery, development and commercialization of antisense drugs for respiratory conditions.…

Articles about Altair Therapeutics' Series A - II Round: